- Action Mechanism in Immunopathogenesis and Clearance of HBV
-
Im SJ, Sung YC
- KMID: 760642
- Korean J Hepatol.
- 2006 Jun;12(2):154-162.
Hepatitis B virus (HBV) currently infects more than 400 million people worldwide and they are at risk of developing chronic liver disease, cirrhosis and hepatocellular carcinoma. The immune response to... -
- CITED
-
- Close
- SHARE
-
- Close
- In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees
-
Kim SH, Oh HK, Ryu CJ, Park SY, Hong HJ
- KMID: 1103597
- Exp Mol Med.
- 2008 Feb;40(1):145-149.
- doi: 10.3858/emm.2008.40.1.145
Previously, we constructed a humanized antibody (HuS10) that binds to the common a antigenic determinant on the S protein of HBV. In this study, we evaluated its HBV-neutralizing activity in... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
-
Yim SY, Kim TH, Jun SS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Um SH, Kim CD, Won NH, Ryu HS
- KMID: 2412216
- Gut Liver.
- 2017 May;11(3):417-425.
- doi: 10.5009/gnl16148
BACKGROUND/AIMS: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Delayed Clearance of Serum HBsAg in Patients with Chronic HBV Infection
-
Nam SW, Jung JJ, Bae SH, Choi JY, Yoon SK, Cho SH, Han JY, Han NI, Yang JM, Lee YS
- KMID: 1091865
- Korean J Intern Med.
- 2007 Jun;22(2):73-76.
- doi: 10.3904/kjim.2007.22.2.73
BACKGROUND: Spontaneous delayed clearance of hepatitis B surface antigen (HBsAg) in patients with chronic HBV infection is a rare event. The aim of this study was to investigate the... -
- CITED
-
- Close
- SHARE
-
- Close
- HBV-specific CD8+ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy
-
Lee CK, Han KH, Suh JH, Cho YS, Won SY, Chon CY, Moon YM, Park IS
- KMID: 760578
- Korean J Hepatol.
- 2005 Mar;11(1):34-42.
BACKGROUND/AIMS: Viral suppression of the hepatitis B virus (HBV) can be induced by lamivudine, but the relapse seen in many patients after cessation of lamivudine therapy is troublesome. We... -
- CITED
-
- Close
- SHARE
-
- Close
